Latest Breaking News On - Arran attridge - Page 1 : comparemela.com

CymaBay Reports Fourth Quarter and Year Ended December 31, 2023 Financial Results and Provides Corporate Update

The New England Journal of Medicine Publishes Positive Phase 3 RESPONSE Data of CymaBay's Seladelpar in Primary Biliary Cholangitis

/PRNewswire/ CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a biopharmaceutical company focused on innovative therapies for patients with liver and other.

The New England Journal of Medicine Publishes Positive Phase 3 RESPONSE Data of CymaBay's Seladelpar in Primary Biliary Cholangitis

Gilead Partners with CHAI and Penta to Improve Treatment and Adherence Rates Among Children with HIV in Low and Middle Income Countries

Pfizer's newest vaccine plant has persistent mold issues, history of recalls

Pfizer’s newest vaccine plant has persistent mold issues, history of recalls Pfizer s management knew last year there was a mold issue at the Kansas facility now slated to produce the drugmaker s urgently needed covid-19 vaccine, according to a Food and Drug Administration inspection report. The McPherson, Kansas, facility, which FDA inspectors wrote is the nation s largest manufacturer of sterile injectable controlled substances, has a long, troubled history. Nearly a decade s worth of FDA inspection reports, recalls and reprimands reviewed by KHN show the facility as a repeat offender. FDA investigators have repeatedly noted in reports that the plant has failed to control quality and contamination or fully investigate after production failures.